Department of Pharmaceutics, SVKM'S B.N. College of Pharmacy, Mumbai, India.
Drug Dev Ind Pharm. 2013 May;39(5):635-45. doi: 10.3109/03639045.2012.683440. Epub 2012 May 8.
Lipid based drug delivery systems have gained prominence in last decade for drugs with dissolution rate limited oral bioavailability.
To improve the solubility, permeability and oral bioavailability of cefpodoxime proxetil, β-lactam antibiotic. It is BCS Class IV drug having solubility 400 µg/mL and 50% oral bioavailability.
Self-nanoemulsifying drug delivery system (SNEDDS) using various surfactant and cosurfactants such as tween 80, tocopheryl polyethylene glycol succinate (TPGS), propylene glycol and Capmul MCM as oil phase were prepared. Ternary phase diagrams were constructed to identify stable microemulsion region. Percent transmittance studies helped to shortlist the surfactant-cosurfactant combination.
Tween 80 and TPGS as surfactants and Capmul MCM as oil phase were found to produce stable nanoemulsions. Five formulations of SNEDDS had globule size of 55-60 nm and zeta potential of -4 to -11 mV. Self-emulsification time was between 221 and 370 s, while viscosity was dependent on composition of SNEDDS. Cloud point was above 70°C which indicated the retention of in vivo self-emulsifying properties. Average flux for cefpodoxime proxetil (CP) and SNEDDS was 0.104 and 0.985 µg/cm(2) min. Permeability was 19.72 and 206 for CP and SNEDDS. Liquid SNEDDS spray coated onto micropellets of microcrystalline cellulose (18-20#) were analysed by scanning electron microscope (SEM), self-emulsification and in vitro dissolution. A 5.36-fold increase in area under curve AUC(0-∞) was observed for CP-SNEDDS than plain drug. Minimum inhibitory concentration (MIC) was lower for SNEDDS. Liquid and SNEDDS micropellets were stable under accelerated conditions.
SNEDDS formulations led to improved oral bioavailability due to enhanced solubilization of selected drug.
在过去十年中,基于脂质的药物递送系统因其具有溶解速率限制的口服生物利用度而备受关注。
提高头孢泊肟酯(β-内酰胺抗生素)的溶解度、渗透性和口服生物利用度。它是 BCS 分类 IV 类药物,溶解度为 400μg/mL,口服生物利用度为 50%。
使用各种表面活性剂和助表面活性剂(如吐温 80、生育酚聚乙二醇琥珀酸酯(TPGS)、丙二醇和 Capmul MCM 作为油相)制备自微乳给药系统(SNEDDS)。构建三元相图以确定稳定的微乳液区域。百分透光率研究有助于筛选表面活性剂-助表面活性剂组合。
发现吐温 80 和 TPGS 作为表面活性剂,Capmul MCM 作为油相可以产生稳定的纳米乳液。SNEDDS 的五个配方的粒径为 55-60nm,Zeta 电位为-4 至-11mV。自乳化时间在 221-370s 之间,而粘度取决于 SNEDDS 的组成。浊点高于 70°C,表明保留了体内自乳化特性。头孢泊肟酯(CP)和 SNEDDS 的平均通量分别为 0.104 和 0.985μg/cm(2)min。CP 和 SNEDDS 的渗透性分别为 19.72 和 206。将液态 SNEDDS 喷雾涂覆到微晶纤维素(18-20#)微丸上,通过扫描电子显微镜(SEM)、自乳化和体外溶解进行分析。与普通药物相比,CP-SNEDDS 的 AUC(0-∞)面积增加了 5.36 倍。SNEDDS 的最低抑菌浓度(MIC)较低。在加速条件下,液态和 SNEDDS 微丸均稳定。
由于所选药物的溶解度提高,SNEDDS 配方导致口服生物利用度提高。